David Wechsler

David Wechsler was affiliated with New York University in the United States and focused primarily on medical research within the field of ophthalmology. Their work spanned several subfields, including ophthalmology, radiology, nuclear medicine and imaging, pathology and forensic medicine, hematology, and public health, environmental and occupational health.

Their research prominently addressed topics such as glaucoma and retinal disorders, retinal diseases and treatments, retinal imaging and analysis, ophthalmology and eye disorders, ocular surface and contact lens, autism spectrum disorder research, and family and disability support research.

Frequent publication venues for their work included:

• International Ophthalmology
• Ophthalmology Glaucoma
• AJO International
• Cureus
• The Lancet

David Wechsler collaborated often with other researchers, with notable frequent co-authors being Mitchell Lawlor, Colin Clement, Jeremy Tan, Andrew White, and Hamish Dunn.

Among their recent papers were:

• "Advancing health-care equity for autistic people: mental health as a key priority," 2025, published in The Lancet
• "Visual rehabilitation in subconjunctival MIGS versus trabeculectomy and tube shunt surgery," 2025, published in AJO International
• "Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma," 2024, published in Ophthalmology Glaucoma
• "Longitudinal outcomes of iStent inject with cataract surgery compared with cataract surgery alone: real-world data from the Fight Glaucoma Blindness registry," 2024, published in Journal of Cataract & Refractive Surgery
• "Five-Year Outcomes of Trabeculectomy and Phacotrabeculectomy," 2021, published in Cureus

Their work contributed to understanding clinical outcomes and treatment efficacy in glaucoma surgery and related ophthalmic procedures. Additionally, Wechsler's research extended into public health areas concerning autism spectrum disorder, emphasizing mental health priorities for autistic people.